| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
(RAR
) Chimeric Proteins PML-, PLZF-, NPM-, and NuMA-RAR
Have Distinct Intracellular Localization Patterns1
The Institute of Medical Sciences [J. L. H., R. A. W., S. K-R.] and Department of Laboratory Medicine and Pathobiology [S. K-R.], University of Toronto, Toronto, Ontario, M5S 1A8; The Ontario Cancer Institute, The Department of Pathology, The University Health Network, Toronto, Ontario, M5G 2M9 [J. L. H., T. Z., S. K-R.], Canada
Retinoic acid receptor
(RAR
) gene rearrangement by reciprocal chromosome translocation is the molecular signature of acutepromyelocytic leukemia (APL). Disruption of RAR
function appears to be the likely cause of aberrant myelopoiesis observed in APL, because PML-RAR
expression has been shown to deregulate the transcription of genes that control myelopoiesis. To target RAR
chimeric proteins, we engineered epitope-tagged versions of PML-RAR
, PLZF-RAR
, NPM-RAR
, and NuMA-RAR
(X-RAR
V5) and generated a panel of stable COS cell lines expressing X-RAR
V5. Protein fractionation and Western analysis of these COS lines reveal that X-RAR
proteins localize to both the cytoplasm and nucleus. NPM-RAR
is predominantly nuclear whereas NuMA-RAR
is predominantly cytoplasmic. Confocal immunofluorescent microscopy reveals that PML-RAR
and PLZF-RAR
share a primarily diffuse nuclear pattern that excludes the nucleolus. NPM-RAR
is also diffuse in the nucleus but, in contrast to PML-RAR
and PLZF-RAR
, is strongly associated with the nucleolus. Strikingly, NuMA-RAR
predominantly localizes throughout the cytoplasm in a microspeckled pattern. We further demonstrate that NPM and NuMA interact with NPM-RAR
and NuMA-RAR
, respectively. The distinct intracellular localization patterns and the shared ability of X-RAR
to interact with their respective RAR
partner proteins (X) further support the hypothesis that deregulation of these partners may play a role in APL pathogenesis.
This article has been cited by other articles:
![]() |
P. C. Abad, I. S. Mian, C. Plachot, A. Nelpurackal, C. Bator-Kelly, and S. A. Lelievre The C terminus of the nuclear protein NuMA: Phylogenetic distribution and structure Protein Sci., October 22, 2004; 13(10): 2573 - 2577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. McConnell, N. Chevallier, W. Berkofsky-Fessler, J. M. Giltnane, R. B. Malani, L. M. Staudt, and J. D. Licht Growth Suppression by Acute Promyelocytic Leukemia-Associated Protein PLZF Is Mediated by Repression of c-myc Expression Mol. Cell. Biol., December 15, 2003; 23(24): 9375 - 9388. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |